Azerbaijan Device Registration Timeline: Certificate Issuance in 7 Working Days and Its Two Start Points
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Article 7.1 establishes two starting points:
Ordinary devices — where the submitted documents contain no deficiencies, the Ministry of Health issues the certificate in the Annex 5 format within 7 working days from the date the applicant submits the documents to the Ministry;
Article 4.4 devices (incorporating a medicinal substance) — the certificate is issued within 7 working days from the date the expertise opinion is submitted to the Ministry of Health.
In addition, Article 7.2 provides that where any information on the certificate changes, a new certificate in the Annex 6 format is issued within 7 working days from the applicant’s submission to the Ministry (for Article 4.4 devices, within 7 working days from submission of the expertise opinion).
At the same time, keep Article 7.12 in view: the period of the legally required expertise of the medicinal substance referred to in Article 4.4 is not counted within the review period of the applicant’s issuance application.
Together these provisions make clear that the famous 7-working-day figure is an issuance-stage guarantee, not an end-to-end registration cycle.
2. Legal basis
- Resolution No. 345 of the Cabinet of Ministers of the Republic of Azerbaijan dated 18 July 2024 on the Rules for State Registration of Medicines, Drug Substances and Medical Devices, Their Entry into the State Register and Maintenance of the State Register (effective 19 July 2024; Xalq qəzeti No. 151 of 20 July 2024; Legislative Bulletin 2024 No. 7, item 906; repealing Resolution No. 108 of 13 July 2007 as of 20 July 2024): Article 7.1 (ordinary devices within 7 working days from submission; Article 4.4 devices within 7 working days from submission of the expertise opinion), Article 7.2 (modification within 7 working days), Article 7.12 (expertise period excluded), Article 6.16 (state fee within 5 working days after notice from the institution), Article 7.3 (deficiency notice within 5 working days), Article 7.4 (remedy within 10 working days, suspension of the deadline), Article 8.1 (certificate valid for 5 years).
- Resolution No. 502 of the Cabinet of Ministers of the Republic of Azerbaijan dated 25 December 2019 on the Rules for Performing Expertise of Medicines (including simplified expertise) (Xalq qəzeti No. 290 of 28 December 2019; Legislative Bulletin 2019 No. 12, item 2083; effective 1 July 2020) — the expertise implementation rules.
- Law of the Republic of Azerbaijan on Licenses and Permits (No. 176-VQ of 15 March 2016), Articles 18.2.1–18.2.3, 19.9, 25 and 26.1 — Article 19.9 (unless a shorter period is provided by another law, the licensing body issues the license or issues an administrative act of refusal no later than 7 working days from the registration of the application) — cited for comparison.
3. Expert insights
Insight one: the 7 working days cover the issuance leg, not the whole journey. Article 7.1 binds the Ministry of Health from receipt of complete documents (or the expertise opinion) to issuance. It excludes dossier preparation time, the AEC expertise period (expressly excluded by Article 7.12) and the deficiency remedy period (expressly suspended and excluded under Article 7.4). Treating 7 working days as the registration cycle is the most common scheduling error.
Insight two: the suspension-and-exclusion mechanism of Article 7.4 cuts both ways. The advantage is that the remedy does not consume the issuance deadline; the disadvantage is that the Ministry has no obligation to progress during the suspension — however long the remedy drags, the issuance drags with it. Back-plan the remedy against the full 10 working days; do not relax because a suspension mechanism exists.
Insight three: the fee window and the issuance window are two independent numbers, 5 and 7. Article 6.16 requires the state fee within 5 working days after the AEC notice; Article 7.1 gives 7 working days for issuance. They start on different dates and involve different recipients (the treasury receives the fee; the Ministry issues the certificate). If the cross-border payment chain is not set up in advance, the 5 working days are easily exceeded.
Insight four: the validity of the new certificate under Article 7.2 is limited by the previous certificate — a deliberate design. On modification a new certificate is issued, but its validity ends with the expiry of the previous one. This prevents modifications from becoming disguised renewals and means modifications do not extend the lifecycle; renewal must still be applied for separately under Article 7.8.
Insight five: the 7 working days echo Article 19.9 of the Law on Licenses and Permits. Article 19.9 provides that, unless another law sets a shorter period, the licensing body issues the license or a refusal act no later than 7 working days from the registration of the application. The device registration timeline aligns with that benchmark, showing a deliberate common measuring stick in the legislative design of deadlines.
4. Practical recommendations
- Schedule as dossier preparation plus expertise (where applicable) plus 7 working days, and list the 5-working-day fee window separately.
- Plan medicinal-substance devices from the expertise-opinion submission date, separately from ordinary devices.
- Back-plan the remedy against 10 working days; do not relax because of the suspension rule, and obtain written receipts for the remedy submission.
- Set up the cross-border payment chain in advance so the fee can be paid within 5 working days of the AEC notice.
- Treat modification under Article 7.2 as its own 7-working-day track, noting that the new certificate does not extend validity.
- Record four dates separately in the log: application registration date, document submission date, expertise-opinion submission date and issuance date.
5. Verification checklist
- □ The two starting points for ordinary devices and Article 4.4 devices are distinguished.
- □ The schedule covers dossier preparation, expertise and the 7-working-day issuance leg.
- □ The 5-working-day fee window is reserved and the payment chain is in place.
- □ The remedy is back-planned against 10 working days with submission receipts retained.
- □ It is confirmed that the new certificate issued on modification does not extend validity.
- □ The log distinguishes application registration, document submission, expertise-opinion submission and issuance dates.
- Article 19 — The 5-day notice and 10-day remedy: deficiency handling and suspension of deadlines: https://www.grzanglobal.com/azerbaijan-medical-device-registration/deficiency-notice-5-days-remedy-10-days/
- Article 20 — The 4 statutory grounds for refusal and the 2-day notice: https://www.grzanglobal.com/azerbaijan-medical-device-registration/four-grounds-for-refusal-2-day-notice/
- Article 11 — The state registration full process: application, expertise and issuance in three stages: https://www.grzanglobal.com/azerbaijan-medical-device-registration/state-registration-full-process/
Regulatory information verified as of October 30, 2026.
GRZAN supports manufacturers and authorised representatives in planning the Azerbaijan issuance timeline for medical devices, from dual starting-point scheduling and fee logistics under Article 6.16 to modification and renewal sequencing. For tailored assistance with your Azerbaijan registration timeline, contact us at info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us